Key LARGO (Glioblastoma Multiforme and Grade 4 Astrocytoma) - Clinical Trial

What is the Purpose of this Study?

We are doing this study to learn more about what causes glioblastoma (GBM), a type of brain cancer, and the factors that affect GBM patients' quality of life.

This research will help us to understand why some people get GBM, including how their genes and health history may contribute to tumor development and progression.

What is the Condition Being Studied?

Glioblastoma Multiforme (GBM) and Grade 4 Astrocytoma

Who Can Participate in the Study?

Adults ages 18+ who:

  • Have a pathologically confirmed diagnosis of glioblastoma multiforme (GBM) or grade 4 astrocytoma
  • Have a working email address
  • Can access and complete an online survey about medical and exposure history

For more information about this study, please contact the study team at GBMsurvey@duke.edu.

Age Group
Adults

What is Involved?

If you choose to join this study, you will:

  • Sign and date a consent form
  • Fill out an online survey
  • Give a small blood sample (from the outer arm) two times - you can do this yourself at home using a kit that we will give you

We will run tests on the blood to look for changes in DNA and white blood cells. The tests are for research only. You can complete the survey even if you choose not to give a blood sample.

You can learn more and sign up on our website: https://Duke.is/KeyLARGO

Study Details

Full Title
Key Longitudinal Associations with Risk and Glioblastoma Outcomes
Principal Investigator
Kyle Walsh
Protocol Number
IRB: PRO00114859
NCT: NCT06625684
Phase
Phase N/A
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate